Voyager Therapeutics Inc (VYGR) Insider Dinah Ph.D. Sah Sells 15,623 Shares
Voyager Therapeutics Inc (NASDAQ:VYGR) insider Dinah Ph.D. Sah sold 15,623 shares of the firm’s stock in a transaction dated Tuesday, February 27th. The stock was sold at an average price of $30.00, for a total transaction of $468,690.00. Following the completion of the sale, the insider now directly owns 140,872 shares of the company’s stock, valued at approximately $4,226,160. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.
Voyager Therapeutics Inc (VYGR) opened at $30.09 on Friday. The company has a market cap of $825.73 and a P/E ratio of -10.60. Voyager Therapeutics Inc has a 12 month low of $8.10 and a 12 month high of $30.83.
Several research firms have recently weighed in on VYGR. Zacks Investment Research raised shares of Voyager Therapeutics from a “sell” rating to a “hold” rating in a research note on Saturday, January 6th. Wedbush lifted their price target on shares of Voyager Therapeutics from $22.00 to $29.00 and gave the company an “outperform” rating in a research note on Wednesday, February 21st. Morgan Stanley lifted their price target on shares of Voyager Therapeutics from $36.00 to $39.00 and gave the company an “overweight” rating in a research note on Wednesday, February 21st. Canaccord Genuity reaffirmed a “buy” rating and set a $26.00 price target on shares of Voyager Therapeutics in a research note on Tuesday, January 23rd. Finally, BidaskClub raised shares of Voyager Therapeutics from a “hold” rating to a “buy” rating in a research note on Friday, January 5th. Two investment analysts have rated the stock with a sell rating, one has assigned a hold rating and eleven have issued a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average target price of $28.00.
COPYRIGHT VIOLATION WARNING: This piece of content was first reported by Watch List News and is the sole property of of Watch List News. If you are reading this piece of content on another publication, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright legislation. The correct version of this piece of content can be viewed at https://www.watchlistnews.com/voyager-therapeutics-inc-vygr-insider-dinah-ph-d-sah-sells-15623-shares/1906621.html.
About Voyager Therapeutics
Voyager Therapeutics, Inc is a clinical-stage gene therapy company. The Company focuses on developing treatments for patients suffering from severe diseases of the central nervous system (CNS). The Company’s pipeline consists of programs for CNS indications, including advanced Parkinson’s disease; a monogenic form of amyotrophic lateral sclerosis (ALS); Huntington’s disease; Friedreich’s ataxia; frontotemporal dementia/Alzheimer’s disease, and severe chronic pain.
Receive News & Ratings for Voyager Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyager Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.